Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07864012 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Physiological and Molecular Adaptations to Different Training Modalities in National-level Kayak Athletes

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This interventional study evaluated physiological, molecular, and performance adaptations to different high-intensity training modalities in national-level kayak athletes. Thirty-two athletes were allocated to four parallel groups: high-intensity interval training (HIIT), sprint interval training (SIT), combined training (COMB), or a control condition (CON). The study protocol included a six-week detraining period before baseline (PRE) assessments, followed by a six-week training intervention and a subsequent six-week detraining period. Physiological assessments and blood sampling were performed at PRE and immediately after the training intervention (POST) to evaluate training-related changes. Sprint kayak performance over 500 m was assessed at PRE and POST, with additional assessments conducted 15 and 30 days after completion of the subsequent six-week detraining period. The study aimed to examine the effects of different training modalities on physiological responses, circulating molecular markers, and 500-m kayak performance, as well as changes in performance following detraining.
Trial Details
NCT Number NCT07864012
Lead Sponsor National and Kapodistrian University of Athens
Conditions Exercise Training Adaptation
Enrollment 32 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov